The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.

As stem cell researchers, we are in a unique position to make real and meaningful impacts in the world. During my time as ISSCR President my goal, beyond serving ISSCR’s role as the main convener of stem cell science, is to strengthen the society’s voice and influence by expanding on our global policy initiatives and helping foster industry-academic partnerships to accelerate the safe and effective clinical translation of stem cell research.